β¨ Medicine Distribution Notices
20 OCTOBER 2005
NEW ZEALAND GAZETTE, No. 177
4499
Product:
Certican
Active Ingredient:
Everolimus 0.25mg
Dosage Form:
Dispersible tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland
Product:
Certican
Active Ingredient:
Everolimus 0.25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland
Product:
Certican
Active Ingredient:
Everolimus 0.5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland
Product:
Certican
Active Ingredient:
Everolimus 0.75mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland
Product:
Certican
Active Ingredient:
Everolimus 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland
Product:
Metamucil Lemon Lime Flavour Smooth Texture
Active Ingredient:
Ispaghula husk 541.38mg/g
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America
Product:
Metamucil Regular Flavour Smooth Texture
Active Ingredient:
Ispaghula husk 583.33mg/g
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America
Product:
Recormon 60,000 for Reco-Pen
Active Ingredient:
Epoetin beta 60,000IU equivalent to 498Β΅g
Dosage Form:
Front compartment Powder for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Dated this 12th day of October 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6928
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Velcade
Active Ingredient:
Bortezomib 3.5mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 177
Gazette.govt.nz —
NZ Gazette 2005, No 177
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare12 October 2005
Medicines, Distribution, Certican, Everolimus, Metamucil, Recormon
- DON MATHESON, Deputy Director-General, Public Health
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social WelfareMedicines, Provisional Consent, Velcade, Bortezomib